Slovakia · Delayed Price · Currency is EUR Biotika a.s. Statistics
Total Valuation
Biotika a.s. has a market cap or net worth of EUR 7.56 million. The enterprise value is 3.85 million.
| Market Cap | 7.56M |
| Enterprise Value | 3.85M |
Important Dates
The next estimated earnings date is Friday, June 26, 2026.
| Earnings Date | Jun 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biotika a.s. has 700,000 shares outstanding.
| Current Share Class | 564,936 |
| Shares Outstanding | 700,000 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.42 |
| PB Ratio | 0.34 |
| P/TBV Ratio | 0.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.28, with a Debt / Equity ratio of 0.14.
| Current Ratio | 3.28 |
| Quick Ratio | 2.25 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.99 |
| Interest Coverage | -35.89 |
Financial Efficiency
Return on equity (ROE) is -5.18% and return on invested capital (ROIC) is -19.46%.
| Return on Equity (ROE) | -5.18% |
| Return on Assets (ROA) | -7.39% |
| Return on Invested Capital (ROIC) | -19.46% |
| Return on Capital Employed (ROCE) | -12.81% |
| Weighted Average Cost of Capital (WACC) | 4.23% |
| Revenue Per Employee | 110,020 |
| Profits Per Employee | -7,206 |
| Employee Count | 165 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.42 |
Taxes
In the past 12 months, Biotika a.s. has paid 3,840 in taxes.
| Income Tax | 3,840 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.92% in the last 52 weeks. The beta is 0.12, so Biotika a.s.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | -16.92% |
| 50-Day Moving Average | 10.37 |
| 200-Day Moving Average | 16.67 |
| Relative Strength Index (RSI) | 52.53 |
| Average Volume (20 Days) | 13 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biotika a.s. had revenue of EUR 18.15 million and -1.19 million in losses. Loss per share was -1.70.
| Revenue | 18.15M |
| Gross Profit | 4.13M |
| Operating Income | -3.61M |
| Pretax Income | -1.19M |
| Net Income | -1.19M |
| EBITDA | -2.31M |
| EBIT | -3.61M |
| Loss Per Share | -1.70 |
Balance Sheet
The company has 6.84 million in cash and 3.13 million in debt, with a net cash position of 3.71 million or 5.31 per share.
| Cash & Cash Equivalents | 6.84M |
| Total Debt | 3.13M |
| Net Cash | 3.71M |
| Net Cash Per Share | 5.31 |
| Equity (Book Value) | 22.25M |
| Book Value Per Share | 31.78 |
| Working Capital | 11.82M |
Cash Flow
In the last 12 months, operating cash flow was -4,650 and capital expenditures -779,987, giving a free cash flow of -784,637.
| Operating Cash Flow | -4,650 |
| Capital Expenditures | -779,987 |
| Depreciation & Amortization | 1.29M |
| Net Borrowing | 2.85M |
| Free Cash Flow | -784,637 |
| FCF Per Share | -1.12 |
Margins
Gross margin is 22.76%, with operating and profit margins of -19.87% and -6.55%.
| Gross Margin | 22.76% |
| Operating Margin | -19.87% |
| Pretax Margin | -6.53% |
| Profit Margin | -6.55% |
| EBITDA Margin | -12.74% |
| EBIT Margin | -19.87% |
| FCF Margin | n/a |
Dividends & Yields
Biotika a.s. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -15.73% |
| FCF Yield | -10.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Biotika a.s. has an Altman Z-Score of 0.99 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.99 |
| Piotroski F-Score | 1 |